1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8 "Hepatology")
fax: 330-325-5910
1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
Liver Biology/Pathobiology
You have full text access to this OnlineOpen article
Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7α-hydroxylase gene expression†
Article first published online: 9 DEC 2008
DOI: 10.1002/hep.22627
Copyright © 2008 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Song, K.-H., Li, T., Owsley, E., Strom, S. and Chiang, J. Y. L. (2009), Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7α-hydroxylase gene expression. Hepatology, 49: 297–305. doi: 10.1002/hep.22627
- †
Potential conflict of interest: Nothing to report.
- ‡
fax: 330-325-5910
Publication History
- Issue published online: 28 DEC 2008
- Article first published online: 9 DEC 2008
- Manuscript Accepted: 9 SEP 2008
- Manuscript Received: 6 JUN 2008
Funded by
- National Institutes of Health. Grant Numbers: DK44442, DK58379, DK92310
References
- 1, . Cholesterol 7 alpha-hydroxylase. J Lipid Res 1977; 18: 135–153.
- 2. Biliary excretion of bile acids and cholesterol in bile fistula rats; bile acids and steroids. Proc Soc Exp Biol Med 1957; 94: 578–582.
- 3, . On the regulation of bile acid formation in the rat liver. Acta Physiol Scand 1958; 43: 1–7.
- 4, , , . Biochemical site of regulation of bile acid biosynthesis in the rat. J Lipid Res 1970; 11: 404–411.
- 5. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 2003; 72: 137–174.
- 6, , , , . Failure of intravenous infusion of taurocholate to down-regulate cholesterol 7 alpha-hydroxylase in rats with biliary fistulas. Gastroenterology 1995; 108: 533–544.
- 7, , , , , , et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 2000; 6: 517–526.
- 8, , , , , , et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 2000; 6: 507–515.
- 9, , , , , . Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000; 102: 731–744.
- 10, , , , , , et al. Redundant pathways for negative feedback regulation of bile acid production. Dev Cell 2002; 2: 721–731.
- 11, , , , , , et al. Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. Dev Cell 2002; 2: 713–720.
- 12, , . Bile acid induction of cytokine expression by macrophages correlates with repression of hepatic cholesterol 7alpha-hydroxylase. J Biol Chem 2000; 275: 21805–21808.
- 13, , , , , , et al. Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4. J Biol Chem 2000; 275: 15482–15489.
- 14, . Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription. Am J Physiol Gastrointest Liver Physiol 2005; 288: G74–G84.
- 15, , , , , , et al. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev 2003; 17: 1581–1591.
- 16, , , . Regulation of complement C3 expression by the bile acid receptor FXR. J Biol Chem 2005; 280: 7427–7434.
- 17, , , , , , et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2005; 2: 217–225.
- 18, , , , , , et al. FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4. Cytokine 1999; 11: 729–735.
- 19, , , , , , et al. Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology 2004; 145: 2594–2603.
- 20, , , , , , et al. Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology 2002; 143: 1741–1747.
- 21, , , , , . Increased carbon tetrachloride-induced liver injury and fibrosis in FGFR4-deficient mice. Am J Pathol 2002; 161: 2003–2010.
- 22, , , , . Independent repression of bile acid synthesis and activation of c-Jun N-terminal kinase (JNK) by activated hepatocyte fibroblast growth factor receptor 4 (FGFR4) and bile acids. J Biol Chem 2005; 280: 17707–17714.
- 23, . Glucagon and cAMP inhibit cholesterol 7alpha-hydroxylase (CYP7A1) gene expression in human hepatocytes: discordant regulation of bile acid synthesis and gluconeogenesis. HEPATOLOGY 2006; 43: 117–125.
- 24, , , , , , et al. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J Biol Chem 2007; 282: 26687–26695.
- 25, , , , , , et al. Identification of a hormonal basis for gallbladder filling. Nat Med 2006; 12: 1253–1255.
- 26, , , , . Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain. Biochim Biophys Acta 1999; 1444: 148–151.
- 27, , , , , , et al. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res 2007; 48: 2664–2672.
- 28, , , . Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J Intern Med 2006; 260: 530–536.
- 29, , . Bile acids and cytokines inhibit the human cholesterol 7 alpha-hydroxylase gene via the JNK/c-jun pathway in human liver cells. HEPATOLOGY 2006; 43: 1202–1210.
- 30, , . Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha). Gene 2001; 262: 257–265.
- 31, . Identification and characterization of a putative bile acid-responsive element in cholesterol 7 alpha-hydroxylase gene promoter. J Biol Chem 1994; 269: 17502–17507.
- 32, , . Identification of a bile acid response element in the cholesterol 7 alpha-hydroxylase gene CYP7A. Am J Physiol 1997; 273: G508–G517.
- 33, , , , , , et al. Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1. Mol Cell Biol 2007; 27: 8330–8339.
- 34, , , , , , et al. Liver receptor homolog-1 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis. Mol Endocrinol 2008; 22: 1345–1356.
- 35. Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. J Hepatol 2004; 40: 539–551.
- 36, , , , , , et al. Co-receptor requirements for fibroblast growth factor-19 signaling. J Biol Chem 2007; 282: 29069–29072.
- 37, , , . Liver-specific activities of FGF19 require Klotho beta. J Biol Chem 2007; 282: 27277–27284.
- 38, , , , , , et al. Farnesoid X receptor protects liver cells from apoptosis induced by serum deprivation in vitro and fasting in vivo. Mol Endocrinol 2008; 22: 1622–1632.